Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 192 participants.
Also called NCT07914660
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 192 participants
- Sponsor
- Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
- Registry
-
NCT07914660
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07914660. Randomized; quadruple masking; primary purpose treatment. Start 2026-11-20 (anticipated); primary completion 2028-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)
- Condition
- Hyperlipoproteinemia (a)
- Intervention (Drug)
- YKYY032 group
- Intervention (Other)
- YKYY032 Placebo group
- Lead sponsor
- Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct07914660- Content hash
d414ade576b2f3e8d74a8db21b1698adf6f0c52fe76084e5ddd0ec1c62abfb89